MedTrace Logo

Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis

NCT07040332 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2025-07-04

No results posted yet for this study

Summary

This study aims to reveal the immune and inflammatory regulatory molecular mechanisms related to the progression of allergic bronchopulmonary aspergillosis (ABPA), and to build a precision typing based on inflammation and identify the biomarkers of typing, and to explore the clinical outcomes of different inflammatory phenotypes.

Conditions

  • Allergic Bronchopulmonary Aspergillosis (ABPA)

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • Shanghai Pulmonary Hospital, Tongji University School of Medicine

    collaborator UNKNOWN

  • Fudan University

    collaborator OTHER

  • Guizhou Provincial People's Hospital

    collaborator OTHER

  • The First Hospital of Jilin University

    collaborator OTHER

  • Qilu Hospital of Shandong University

    collaborator OTHER

  • Qianfoshan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-10
Primary Completion
2027-07-31
Completion
2029-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07040332 on ClinicalTrials.gov